Circulating serum amyloid A levels but not SAA1 variants predict long-term outcomes of angiographically confirmed coronary artery disease

Yeh, Kuan-HungKuan-HungYehHsu, Lung-AnLung-AnHsuJYH-MING JIMMY JUANGFU-TIEN CHIANGTeng, Ming-ShengMing-ShengTengTzeng, I-ShiangI-ShiangTzengWu, SemonSemonWuLin, Jeng-FengJeng-FengLinKo, Yu-LinYu-LinKo2023-02-152023-02-15202210163190https://scholars.lib.ntu.edu.tw/handle/123456789/628163Circulating serum amyloid A (SAA) levels are strongly associated with atherosclerotic cardiovascular disease risk and severity. The association between SAA1 genetic variants, SAA levels, inflammatory marker levels, and coronary artery disease (CAD) prognosis has not been fully understood.enCoronary artery disease; Genome-wide association study; Long-term outcomes; SAA1 gene; Serum amyloid A[SDGs]SDG3Circulating serum amyloid A levels but not SAA1 variants predict long-term outcomes of angiographically confirmed coronary artery diseasejournal article10.4103/tcmj.tcmj_219_21365786462-s2.0-85140758415https://api.elsevier.com/content/abstract/scopus_id/85140758415